Enzyme replacement therapy (ERT) is the primary treatment for managing systemic symptoms of Morquio syndrome. However, it has limited effectiveness in reversing ocular complications like corneal clouding or glaucoma, as these issues typically result from GAG deposition in tissues that are less accessible to the enzyme.